As a follow up to recent communications surrounding Direct to Patient (DTP) services in China during the coronavirus outbreak, we continue to update you as the situation evolves.
Marken teams are providing DTP services in many cities across China. Challenges to the process do exist and each DTP opportunity will be implemented as requested by clients so that we can evaluate the resources available as well as examine the geographic area requested for DTP services. Marken now has the ability to transport shipments into quarantined areas by working with a dedicated qualified local service provider who has the licenses to operate into and out of the quarantined zones. This has significantly expanded our coverage and capabilities. Additional supplies and new DTP requests are dependent upon conditions in each city or zone and we continue to coordinate daily with our local teams.
Temperature controlled monitoring devices and packaging within quarantined areas may be limited and potentially may not be available for return. We will investigate the most efficient solution to reach patients aligned with their treatment schedules and will manage requests on a case by case basis. You should contact your local Marken office if you wish to implement DTP for your trial in China so that our teams can investigate local regulations and check with hospitals as well as regulatory bodies confirming that the service will be accepted in that area.
Marken is not able to access these zones: Wuhan, Ezhou, Xiantao, Zhijiang, Qianjiang, Huanggang, Chibi, Jingmen, Xianning, Huangshi, Dangyang, Enshi, Xiaogan, Yichang, Jinzhou, Suizhou, Shiyan, Xiangyang, Henan province, Anhui province, Heilongjiang province, Wenzhou, Hangzhou and Taizhou where both Marken and local service providers cannot access at this moment.
The situation changes daily. We encourage you to continue communication with your local Marken contact directly for the most up to date information.Back to Index